# The Application of Novel Oncolytic Virus in Late Stage Solid Tumors

> **NCT06080984** · PHASE1 · UNKNOWN · sponsor: **West China Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Malignant Tumor

## Interventions

- **DRUG:** Oncolytic Virus SDJ001
- **DRUG:** Oncolytic Virus YD06-1

## Key facts

- **NCT ID:** NCT06080984
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-15
- **Primary completion:** 2024-10-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06080984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06080984, "The Application of Novel Oncolytic Virus in Late Stage Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06080984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*